Topical skin formulations

Abstract

A method of treating skin is disclosed. The method can include topically applying to a person's skin a composition comprising 0.0001% to 5% w/w of a hydrolyzed algae extract comprising exopolysaccharides from Halymenia durvillei, and 0.0001% to 5% w/w of a saccharide isomerate comprising an exopolysaccharide synthesized by Vibrio alginolyticus, wherein at least one of skin permeability is decreased, filaggrin production is increased, skin moisture is increased, occludin production is increased, or TNFα production is inhibited in the skin.

1 .- 10 . (canceled) 
     
     
         11 . A method of treating skin having a fine line or wrinkle, the method comprising topically applying to a person's skin having the fine line or wrinkle an oil-in-water emulsion composition comprising:
 hydrolyzed algae extract;   saccharide isomerate;   glycerin;   caprylic/capric triglyceride;   propanediol;   cetearyl alcohol;     Calendula officinalis  extract;     Olea europaea  oil;   cetearyl glucoside;     sclerotium  gum; and   citric acid,   
       wherein the appearance of the fine line or wrinkle is reduced. 
     
     
         12 . The method of  claim 11 , wherein the hydrolyzed algae extract is present in a concentration sufficient to increase production of filaggrin, increase skin moisture, increase production of occludin, and/or decrease skin permeability in the skin. 
     
     
         13 . The method of  claim 11 , wherein the saccharide isomerate is present in a concentration sufficient to increase production of filaggrin, increase skin moisture, increase production of occludin, and/or inhibit TNFα production in the skin. 
     
     
         14 . The method of  claim 11 , wherein the composition is formulated as at least one of a moisturizer, a mask, a foundation, a freshener, or a cleanser. 
     
     
         15 . The method of  claim 11 , wherein the composition further comprises 35% to 98% w/w of water. 
     
     
         16 . The method of  claim 11 , wherein skin permeability is decreased in the skin. 
     
     
         17 . The method of  claim 11 , wherein filaggrin production is increased in the skin. 
     
     
         18 . The method of  claim 11 , wherein skin moisture is increased in the skin. 
     
     
         19 . The method of  claim 11 , wherein occludin production is increased in the skin. 
     
     
         20 . The method of  claim 11 , wherein TNFα production is decreased in the skin. 
     
     
         21 . The method of  claim 11 , wherein the hydrolyzed algae extract comprises exopolysaccharides from  Halymenia durvillei.    
     
     
         22 . The method of  claim 11 , wherein the saccharide isomerate comprises an exopolysaccharide synthesized by  Vibrio alginolyticus.    
     
     
         23 . The method of  claim 11 , wherein the hydrolyzed algae extract comprises exopolysaccharides from  Halymenia durvillei  and the saccharide isomerate comprises an exopolysaccharide synthesized by  Vibrio alginolyticus.